Workflow
REGENXBIO(RGNX) - 2020 Q4 - Earnings Call Transcript
RGNXREGENXBIO(RGNX)2021-03-02 03:05

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2020 Earnings Conference Call March 1, 2021 4:30 PM ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - President and CEO Steve Pakola - Chief Medical Officer Olivier Danos - Chief Scientific Officer Vit Vasista - CFO Conference Call Participants Esther Rajavelu - UBS Lisa Walter - RBC Capital Operator Good afternoon, and welcome to the REGENXBIO Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen- ...